New hepatic vein reconstruction in left liver graft

Nobuyuki Takemura, Yasuhiko Sugawara, Takuya Hashimoto, Nobuhisa Akamatsu, Yoji Kishi, Sumihito Tamura, Masatoshi Makuuchi – 17 February 2005 – The incidence of hepatic venous stenosis is higher in partial liver transplantation. New methods for hepatic venous reconstruction in left liver transplantation, which secure wide anastomosis, were devised and are reported here. In the graft, the right side of the middle hepatic vein or the left side of the left hepatic vein was cut longitudinally and a rectangular‐shaped vein patch was attached for venoplasty.

Hepatic venous outflow reconstruction in right live donor liver transplantation

Massimo Malago, Ernesto P. Molmenti, Andreas Paul, Silvio Nadalin, Hauke Lang, Arnold Radtke, Chao Liu, Andrea Frilling, Reza Biglarnia, Christoph E. Broelsch – 17 February 2005 – The increasing experience with live donor liver transplantation has allowed for the identification of potential morbidities associated with technical considerations. Technical graft failure can be associated with both inflow and outflow vascular compromise. Although the latter has not always been given the relevance of the former, evidence pointing to its pivotal role continues to mount.

Short‐term administration of (‐)‐epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice

Ryan N. Fiorini, Jennifer L. Donovan, David Rodwell, Zachary Evans, Gang Cheng, Harold D. May, Charles E. Milliken, John S. Markowitz, Crystal Campbell, Julia K. Haines, Michael G. Schmidt, Kenneth D. Chavin – 17 February 2005 – Hepatic steatosis increases the extent of cellular injury incurred during ischemia/reperfusion (I/R) injury. (‐)‐Epigallocatechin gallate (EGCG), the major flavonoid component of green tea (camellia sinensis) is a potent antioxidant that inhibits fatty acid synthase (FAS) in vitro.

Safety of donor right hepatectomy without abdominal drainage: A prospective evaluation in 100 consecutive liver donors

Chi Leung Liu, Sheung Tat Fan, Chung Mau Lo, See Ching Chan, Boon Hun Yong, John Wong – 17 February 2005 – Although the role of routine abdominal drainage after liver resection for tumors has been questioned, abdominal drainage after donor right hepatectomy for live donor liver transplantation (LDLT) has been a routine practice in most transplant centers. The present study aimed to evaluate the safety of the procedure without abdominal drainage. A prospective study was performed on 100 consecutive liver donors who underwent right hepatectomy for LDLT from July 2000 to September 2003.

Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone

Andres E. Ruf, Walter K. Kremers, Lila L. Chavez, Valeria I. Descalzi, Luis G. Podesta, Federico G. Villamil – 17 February 2005 – In this study, we investigated the prognostic value of serum sodium and hyponatremia (≤130 mEq/L) in 262 cirrhotic patients consecutively listed, 19 of which died (7%), 175 survived (67%), and 68 underwent liver transplantation (26%) during 3 months of follow‐up.

Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially‐enhancing liver mass

Jorge A. Marrero, Hero K. Hussain, Hahn V. Nghiem, Ramsey Umar, Robert J. Fontana, Anna S. Lok – 17 February 2005 – In the United States, cirrhotic patients with known or suspected hepatocellular carcinoma (HCC) are prioritized for liver transplantation. Noninvasive criteria for the diagnosis of HCC rely on arterial enhancement of a mass. The aim of this study was to determine whether clinical, laboratory, and / or radiologic data can improve the prediction of HCC in cirrhotic patients with an arterially‐enhancing mass.

Subscribe to